CGI Inc. Cl A Stock Rises Thursday, Outperforms Market
Dow Jones2026/10/08 20:32This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of CGI Inc. Cl A GIB.A inched 0.70% higher to C$98.98 Thursday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index rising 0.30% to 35,145.38. CGI Inc. Cl A closed 25.0% short of its 52-week high of C$131.97, which the company reached on January 8th. Trading volume of 485,255 shares remained below its 50-day average volume of 593,530. Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires October 08, 2026 16:32 ET (20:32 GMT)
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of CGI Inc. Cl A GIB.A inched 0.70% higher to C$98.98 Thursday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index rising 0.30% to 35,145.38.
CGI Inc. Cl A closed 25.0% short of its 52-week high of C$131.97, which the company reached on January 8th.
Trading volume of 485,255 shares remained below its 50-day average volume of 593,530.
Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 08, 2026 16:32 ET (20:32 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.
The White House did not intervene in the decision-making of Nvidia's board of directors.
Crypto prices
More
